ArcherDX
The provided URL returned a 404 page indicating the domain is pointed to a hosting provider (WP Engine) but is not configured for an account. No company-specific content, capabilities, or contact information was present on the page.
Industries
Nr. of Employees
medium (51-250)
ArcherDX
Patents
Methods for determining a nucleotide sequence contiguous to a known target nucleotide sequence
US-11781179-B2
View DetailsMethods for determining a nucleotide sequence contiguous to a known target nucleotide sequence
US-10718009-B2
View DetailsMethods for determining a nucleotide sequence contiguous to a known target nucleotide sequence
US-10017810-B2
View DetailsMethods for determining a nucleotide sequence contiguous to a known target nucleotide sequence
US-9487828-B2
View Details
Methods for determining a nucleotide sequence contiguous to a known target nucleotide sequence
US-11781179-B2
View DetailsMethods for determining a nucleotide sequence contiguous to a known target nucleotide sequence
US-10718009-B2
View DetailsMethods for determining a nucleotide sequence contiguous to a known target nucleotide sequence
US-10017810-B2
View DetailsMethods for determining a nucleotide sequence contiguous to a known target nucleotide sequence
US-9487828-B2
View DetailsProducts
LiquidPlex
Sensitive variant detection panel series from liquid biopsies.
LiquidPlex ctDNA 28
The LiquidPlex ctDNA 28 RUO panel for Illumina is an advanced and user-friendly solution for targeted next-generation sequencing of circulating cell-free tumor DNA from 28 genes commonly associated with solid tumor type cancers.
VariantPlex
The VariantPlex Core Solid Tumor panel is a targeted next-generation sequencing (NGS) assay to detect copy number variations (CNVs), single-nucleotide variants (SNVs), insertions and deletions (indels), and microsatellite instability (MSI) status in 60 cancer-implicated genes.
VARIANTPlex Hereditary Cancer
The VARIANTPlex Hereditary Cancer panel is a targeted next-generation sequencing (NGS) research product for the detection of single nucleotide variants, insertions, deletions, and copy number variants in 55 genes relevant in the study of inherited cancers.
VariantPlex® Solid Tumor Focus v2
Catalog panel for targeted solid tumor variant profiling.
VARIANTPlex™ BRCA+PALB2 v2
Catalog panel for BRCA and PALB2 gene mutation testing.
LiquidPlex
Sensitive variant detection panel series from liquid biopsies.
LiquidPlex ctDNA 28
The LiquidPlex ctDNA 28 RUO panel for Illumina is an advanced and user-friendly solution for targeted next-generation sequencing of circulating cell-free tumor DNA from 28 genes commonly associated with solid tumor type cancers.
VariantPlex
The VariantPlex Core Solid Tumor panel is a targeted next-generation sequencing (NGS) assay to detect copy number variations (CNVs), single-nucleotide variants (SNVs), insertions and deletions (indels), and microsatellite instability (MSI) status in 60 cancer-implicated genes.
VARIANTPlex Hereditary Cancer
The VARIANTPlex Hereditary Cancer panel is a targeted next-generation sequencing (NGS) research product for the detection of single nucleotide variants, insertions, deletions, and copy number variants in 55 genes relevant in the study of inherited cancers.
VariantPlex® Solid Tumor Focus v2
Catalog panel for targeted solid tumor variant profiling.
VARIANTPlex™ BRCA+PALB2 v2
Catalog panel for BRCA and PALB2 gene mutation testing.